LGU-37950-78255
3 vaccinations
3 coded responses
34 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 017 / MA
- Registered
- 2022-06-27
- Relationship
- Child or adolescent in my care
- Guardian
- 3QB-28477-29366
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Dose 1 — Pfizer-BioNTech
-
2022-06-27
Registered in v-safe
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-01
- 2022-07-02
- 2022-07-09
-
2022-07-16
Survey response — day 21, dose 1, dependentMedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-07-17
Dose 2 — Pfizer-BioNTech
- 2022-07-17
- 2022-07-18
- 2022-07-20
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-31
- 2022-08-07
- 2022-08-14
- 2022-08-23
- 2022-08-30
-
2022-10-16
Survey response — 3 months, dose 2, dependentMedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: She got a cold, unlikely related to her vaccine just the time of year.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-16
Report sent to call center — 3 months, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-11-26
Dose 3 — Pfizer-BioNTech
-
2022-11-28
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Arthralgia — Feeling: Good · Joint pains, Muscle or body achesFree text: Complaint of pain behind the knees (could also be growing pains)MedDRA releases: 2024-11 · check-in free text available
- 2022-11-29
- 2022-11-30
- 2022-12-01
- 2022-12-02
- 2022-12-05
- 2022-12-10
- 2022-12-19
- 2022-12-24
- 2022-12-31
- 2023-01-07
- 2023-02-27
- 2023-05-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Pfizer-BioNTech | No |
| 2 | 2022-07-17 | Pfizer-BioNTech | No |
| 3 | 2022-11-26 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-16 | Successful 2022-10-17 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 — day 21, dose 1, dependent
Symptoms: Runny nose
Release 12 — 3 months, dose 2, dependent
Symptoms: She got a cold, unlikely related to her vaccine just the time of year.
Release 12 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Complaint of pain behind the knees (could also be growing pains)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release